[Form 4] APOGEE ENTERPRISES, INC. Insider Trading Activity

Rhea-AI Filing Summary

Apogee Enterprises director Lloyd E. Johnson reported receiving 129 deferred restricted stock units (RSUs) on 09/30/2025 under the company's Non-Employee Director Stock Plans. The RSUs were allocated pursuant to a dividend-equivalent reinvestment feature and will settle 1-for-1 into shares of common stock upon the director's board departure or other plan-specified events. The filing shows a reported grant price of $43.57 per share for record purposes and that Mr. Johnson beneficially owns 21,837 shares following the transaction. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Positive

• Director received 129 deferred RSUs via dividend-equivalent reinvestment on 09/30/2025
• RSUs settle 1-for-1 into common shares, reinforcing alignment with shareholders

Negative

• None.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Johnson Lloyd Emerson

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MN 55435

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Restricted Stock Units(1)	(2)	09/30/2025		A(3)		129		(1)	(1)	Common Stock	129	$43.57	21,837	D

Explanation of Responses:

1. The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

2. Settled 1-for-1.

3. Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan.

Remarks:

	/s/Meghan M. Elliott, Attorney-in-Fact for Lloyd E. Johnson	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did APOG director Lloyd E. Johnson report on Form 4?

He reported acquisition of 129 deferred restricted stock units on 09/30/2025 under the company's director stock plans.

How will the deferred RSUs reported for APOG be settled?

The RSUs will be settled 1-for-1 into common stock following the director's termination from the Board or other plan-specified events.

What is the reported price and total beneficial ownership after the transaction for APOG?

The filing lists a price of $43.57 and shows beneficial ownership of 21,837 shares after the reported transaction.

When was the APOG Form 4 executed and filed?

The transaction date is 09/30/2025 and the Form 4 was signed by an attorney-in-fact on 10/02/2025.

Under which plans were the RSUs allocated for APOG's director?

The RSUs were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan.